Effect of Pyridorin in Patients With Diabetic Nephropathy

Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes

NCT00063583 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Pentoxifylline in Diabetic Kidney Disease

NCT03625648 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

NCT03471117 ·Status: RECRUITING ·Phase: PHASE4

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

NCT01200394 ·Status: COMPLETED ·Phase: PHASE2

Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy

NCT00324675 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease

NCT02540993 ·Status: COMPLETED ·Phase: PHASE3

Effect of Sulodexide in Overt Diabetic Nephropathy

NCT00130312 ·Status: TERMINATED ·Phase: PHASE4

A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes

NCT05254002 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

NCT02545049 ·Status: COMPLETED ·Phase: PHASE3

A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy

NCT01488877 ·Status: TERMINATED ·Phase: PHASE1

The Effect of Renin Inhibition on Nerve Function in Diabetes

NCT00935064 ·Status: COMPLETED ·Phase: NA

Effects of PH3 in Diabetic Nephropathy

NCT01068041 ·Status: COMPLETED ·Phase: PHASE2

Niclosamide Role in Diabetic Nephropathy

NCT04317430 ·Status: COMPLETED ·Phase: PHASE3

A Single Oral Dose Study Of PF-06409577 In Healthy Adult Subjects

NCT02286882 ·Status: TERMINATED ·Phase: PHASE1

Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function

NCT01478399 ·Status: COMPLETED ·Phase: PHASE1

Role of Finerenone in African American Veterans With Diabetic Kidney Disease

NCT07155694 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Study to Assess PK, Safety and Tolerability in Patients With DM and CKD

NCT03795389 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment

NCT01555008 ·Status: COMPLETED ·Phase: PHASE1

Benfotiamine in Diabetic Nephropathy

NCT00565318 ·Status: COMPLETED ·Phase: PHASE4

Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient

NCT03159832 ·Status: UNKNOWN ·Phase: PHASE1

Glargine Versus NPH in Patients With Chronic Kidney Disease

NCT02451917 ·Status: COMPLETED ·Phase: PHASE4

A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.

NCT04661917 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well Tolerated

NCT03550378 ·Status: COMPLETED ·Phase: PHASE2

Renal and Peripheral Hemodynamic Function in Patients With Type 1 Diabetes Mellitus

NCT00297401 ·Status: COMPLETED ·Phase: PHASE3

A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes

NCT05901831 ·Status: COMPLETED ·Phase: PHASE3